Epistar Signs LED Collaboration and IP Licensing Agreement With Intermolecular

Epistar Signs LED Collaboration and IP Licensing Agreement With Intermolecular

Accelerating R&D of New Materials and Manufacturing Processes for LEDs Using
Intermolecular's Combinatorial Technology Platform

SAN JOSE, Calif., April 22, 2013 (GLOBE NEWSWIRE) -- Intermolecular, Inc.
(Nasdaq:IMI) announces today that Epistar, Corp. (TWSE:2448) and
Intermolecular, Inc. (Nasdaq:IMI), have signed a collaborative development
program (CDP) and royalty-bearing IP licensing agreement to increase the
efficiency and reduce cost of Epistar's light emitting diode (LED) devices.
Under this agreement, Epistar and Intermolecular engineers will work together
to leverage Intermolecular's High Productivity Combinatorial (HPC™) technology
platform to dramatically accelerate development and manufacturing
qualification of novel materials and processes for advanced LED products.

"After a rigorous review of Intermolecular's capabilities through an initial
collaboration engagement, we have seen how their combinatorial approach to
materials innovation and device integration can augment Epistar's leadership
in LED technology," said M. J. Jou, president of Epistar. "Collaboration with
our industry partners has been critical to our world-leading R&D and
manufacturing strategy. We are confident that leveraging Intermolecular's team
and technology platform will further increase our competitive advantage."

The commercial LED market is highly competitive, and new technologies created
by R&D are needed to both improve light output and to reduce costs. A
multi-functional team of technologists from Epistar and Intermolecular will
work together using the HPC Platform to accelerate the pace of R&D ten times
or more compared to what can be achieved in a conventional LED lab.

"We are very excited to partner with Epistar, a global leader in LED
manufacturing," commented Sandeep Nijhawan, senior vice president and general
manager of Intermolecular's clean energy group. "Entering into a strategic
engagement with a top-tier LED company like Epistar validates the
applicability and disruptive potential of the HPC technology platform for
LEDs, a market that continues to have tremendous room for growth and
technology innovation."

Intermolecular's mission is to improve R&D efficiency in the semiconductor and
clean energy industries through collaborations that use its HPC platform,
which allows R&D experimentation to be performed at speeds up to 100 times
faster than traditional methods.

Forward-Looking Statements

Statements made in this press release that are not statements of historical
fact are forward-looking statements. Forward-looking statements are subject to
the "safe harbor" provisions of the Private Securities Litigation Reform Act
of 1995. Forward-looking statements in this press release relate, but are not
limited, to the Company's expectations for any incremental revenue related to
the technology that is being leveraged. Forward-looking statements are subject
to risks and uncertainties that could cause actual results to differ
materially from expectations, including but not limited to risks detailed from
time to time under the heading "Risk Factors" in the Company's report on Form
10-K for fiscal year 2011, and its subsequent reports on Form 10-Q for fiscal
year 2012. The Company disclaims any intention or obligation to update or
revise any forward-looking statements, whether as a result of new information,
future events or otherwise.

About Intermolecular, Inc.

Intermolecular® has pioneered a proprietary approach to accelerate research
and development, innovation, and time-to-market for the semiconductor and
clean energy industries. The approach consists of its proprietary HPC™
platform, coupled with its multi-disciplinary team. Through paid collaborative
development programs (CDPs) with its customers, Intermolecular develops
proprietary technology and intellectual property for its customers focused on
advanced materials, processes, integration and device architectures. Founded
in 2004, Intermolecular is based in San Jose, California. "Intermolecular" and
the Intermolecular logo are registered trademarks; and "HPC" is a trademark of
Intermolecular, Inc.; all rights reserved. Learn more at
www.intermolecular.com.

CONTACT: Press Contact
         David Moreno
         MCA Public Relations
         dmoreno@mcapr.com
         +1.650.968.8900 x125
        
         Investors
         Gary Hsueh, Intermolecular
         Sr. Director of Corporate Development and Investor Relations
         gary.hsueh@intermolecular.com
         +1.408.582.5635

Intermolecular, Inc. Logo
 
Press spacebar to pause and continue. Press esc to stop.